Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin  by Busse, Rudi & Mülsch, Alexander
Volume 265, number 1,2, 133-136 FEBS 08487 June 1990 
Calcium-dependent itric oxide synthesis in endothelial cytosol is 
mediated by calmodulin 
Rudi Busse and Alexander Mfilsch 
Department of Applied Physiology, University of Freiburg, Hermann-Herder-Str. 7, D-7800 Freiburg, FRG 
Received 2 April 1990; revised version received 18 April 1990 
We investigated whether calmodulin mediates the stimulating effect of Ca2+ on nitric oxide synthase in the cytosol of porcine aortic endothelial 
cells. Nitric oxide was quantified by activation of a purified soluble guanylate cyclase. The Ca*+ -sensitivity of nitric oxide synthase was lost after 
anion exchange chromatography of the endothelial cytosol and could only be. reconstituted by addition of cahnodulin or heat-denatured endothelial 
cytosol. The CaZf-dependent activation of nitric oxide synthase in the cytosol was inhibited by the calmodulin-binding peptides/proteins melittin, 
mastoparan, and calcineurin (IC,, 450, 350 and 60 nM, respectively), but not by the calmodulin antagonist, calmidazolium. In contrast, Ca2+- 
calmodulin-reconstituted nitric oxide synthase was inhibited with similar potency by melittin and calmidazolimn. The results suggest hat the CaZ+- 
dependent activation of nitric oxide synthaae in endothelial cells is mediated by calmodulin. 
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1. INTRODUCTION 
Endothelial cells synthetize and release a labile factor 
that relaxes vascular smooth muscle (endothelium- 
derived relaxing factor; EDRF) [l] via stimulation of 
soluble guanylate cyclase [2]. This factor is identical or 
closely related to nitric oxide [3]. An enzyme activity 
present in the cytosol of endothelial cells catalyzes 
the formation of nitric oxide from L-arginine in a 
NADPH-dependent manner [4,5]. It has been shown 
that the cytosolic nitric oxide formation is activated by 
free Ca2+ [4,5] in concentrations which occur upon 
stimulation with EDRF/nitric oxide-releasing agonists 
[6]. However, the mechanism by which this Ca2’- 
dependence is achieved in endothelial cells is still 
unknown. Therefore, the objective of the present study 
was to investigate whether calmodulin mediates the 
regulatory function of Ca2+ on endothelial nitric oxide 
synthase. We studied the effect of several natural and 
pharmacological calmodulin antagonists as well as ex- 
ogenously added calmodulin on nitric oxide formation 
by crude and partially purified nitric oxide synthase 
from porcine aortic endothelial cells. 
recently [4,7]. Cells were washed 2 times in 15 mM Hepes, pH 7.5 
(lOOOxg, 5 min, 4”C), disintegrated by sonication (3 x 10 s, 100 W), 
and centrifuged (1 h, 100 000 x g) for preparation of the cytosol. For 
removal of the endogenous calmodulin, the cytosol was loaded on a 
Mono-Q column (Pharmacia, Freiburg, FRG) and nitric oxide syn- 
thase was eluted with a linear salt gradient (O-O.5 M NaCl). Active 
fractions were pooled and aliquots were stored at -30°C. Protein 
content was determined by the Biorad assay (Biorad, Mtlnchen, 
FRG). 
2.2. Detection of cytosolic oxide formation by activation of soluble 
guanylate cyclase 
Crude or partially purified nitric oxide synthase (0.1 mg pro- 
tein/ml) was incubated (30 min) at 37°C (final volume 50 ~1) in a buf- 
fer containing 1 pg/ml homogeneously purified guanylate cyclase 
from bovine lung [4] and (in mM) 0.3 L-arginine, 0.1 NADPH, 0.1 
[cr-“PlGTP(0.2 &i), 0.1 cGMP, 2 glutathione, 15 Hepes, pH 7.5, 
4 MgClx, 1,3-isobutyl-1-methylxanthine, 3.5 creatine phosphate, 4.8 
units creatine phosphokinase, 0.1 mg/ml bovine y-globulin and 0.1 
EGTA. Isolation of [32P] cGMP and calculation of guanylate cyclase 
activity (nmol cGMP per min per mg purified guanylate cyclase) was 
performed as described [4]. Endothelial guanylate cyclase activity ac- 
counted for about 1% of the cGMP formed in the presence of 
purified guanylate cyclase and was therefore not considered for 
calculation of the results. The concentration of free Ca2+ was ad- 
justed by addition of CaClx and was quantified by fluorescence 
measurement with the fluorescent Ca2+ indicator, indo-l [6]. 
2. MATERIALS AND METHODS 
2.1. Isolation of endothelial cells and preparatin of cytosol 
Endothelial cells were isolated from porcine aortae as described 
2.3. Determination of the calmodulin content of endothelial cytosol 
The content of endogenous calmodulin in the cytosolic prepara- 
tions was determined by radioimmunoassay. Non-heated calmodulin 
standard was used for calibration, since endothelial cytosol was not 
heated during the preparation. Cytosolic preparations contained 
1.9 f 0.6 mg protein/ml (n = 27) and were diluted IO-20-fold. 
2.4. Materials 
Correspondence address: R. Busse, Department of Applied Physio- 
logy, University of Freiburg, Hermann-Herder-Str. 7, D-7800 Frei- 
The calmodulin-RIA kit was obtained from NEN DuPont (Bad 
Homburg, FRG). The second (precipitating) antibody (donkey anti- 
burg, FRG sheep IgG) directed against the primary calmodulin antibody, 
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calcineurin (bovine brain, 3000 units/mg protein), melittin, 
mastoparan, calmidazolium (R 24571), and trifluoperazin were pur- 
chased from Sigma (Munchen, FRG). Porcine brain calmodulin and 
insulin were supplied by Boehringer (Mannheim, FRG). L-arginine, 
and NADPH were from Serva (Heidelberg, FRG). Fendiline-HCl 
was kindly donated by Thiemann Arzneimittel (Waltrop, FRG). 
Calcineurin was dissolved in bidistilled water and passed through a 
Sephadex G25 column (2ml) equilibrated with 15 mM Hepes, 
pH 7.5, to remove low molecular weight constituents of the 
lyophilisate. Proteins and peptides were diluted in 15 mM Hepes, 
pH 7.5, containing 0.1 mg/ml bovine -r-globulin. All other sub- 
stances were supplied and solutions were prepared as described [4,7]. 
2.5. Data evaluation 
Data represent means &SE of at least 3 independent determina- 
tions, each performed in triplicate, if not indicated otherwise. 
Significance of differences was tested by the Student’s t-test, with the 
Bonferroni-correction for the comparison of multiple means [8]. 
P< 0.05 was considered significant. 
3. RESULTS 
The activity of a purified soluble guanylate cyclase 
was stimulated from 23.0 f 1.5 nmol - mg-’ - min-’ to 
56.0+ 2.8 nmol - mg-’ . min-’ (n = 20) by endothelial 
cytosol (0.1 mg protein/ml) in nominally Ca’+-free 
buffer (about 20 nM free Ca’+). Guanylate cyclase ac- 
tivity was further increased to 129.0* 8.3 nmol - mg-’ 
(n = 20) by 2 PM free Ca2+, indicating a direct 
Ca2+-dependency of endothelial nitric oxide synthase. 
The half-maximal effect of Ca2+ was observed 
with 0.3 PM free Ca 2+ Addition of bovine brain calmo- .
dulin (3 pM) increased guanylate cyclase activity from 
51 f 6 to 100 + 9 nmol - mg-’ - min-’ in the presence of 
10 nM free Ca2+ and from 174kll.S to 212+15 
nmol - mg-’ - min-’ in the presence of 2 PM free Ca2+. 
The effects of calmodulin were not mimicked by other 
colmodulin IpMl 
Fig. 1. Ca’+-calmodulin-dependence of nitric oxide formation by 
partially purified nitric oxide synthase. Nitric oxide synthase was co- 
incubated with purified guanylate cyclase (GC) at two different 
Ca*+-concentrations (20nM (*) and 2 pM (o) free Ca’+) with 
increasing concentrations of calmodulin in the presence of L-arginine 
(0.3 mM) and NADPH (0.1 mM) for 30 min at 37’C. Data are means 
&SE of 3 independent experiments. 
colmodulin ontogonists log [MI colmodulin ontogomsts log [Ml 
Fig. 2. Effects of calmodulin inhibitors (calcineurin (o), melittin ( v ), 
mastoparan (a) and calmidazolium (q ) on nitric oxide-formation by 
partially purified Ca*+-calmodulin-reconstituted nitric oxide synthase 
(a) and by endothelial cytosol (b). Effects were quantified by 
inhibition of guanylate cyclase (GC) activity ((‘70 of control in the 
absense of inhibitors). Ca’+-calmodulin (0.3 CM)-reconstituted nitric 
oxide synthase (a) or endothelial cytosol (b) was incubated with 
purified GC at different concentrations of calmodulin inhibitors in 
the presence of L-arginine (0.3 mM) and NADPH (0.1 mM) for 30 
min at 37°C. For further details see text. Results from at least 3 
independent experiments performed in triplicate. 
hydrophobic proteins like insulin or bovine serum 
albumin (data not shown). Heat-denatured endothelial 
cytosol (10 min, 95°C; 0.05 mg protein/ml) did not ac- 
tivate guanylate cyclase in the presence of L-arginine, 
but significantly increased the calcium-dependent 
activation of guanylate cyclase in the presence of native 
endothelial cytosol (0.05 mg protein/ml) by 35 f 7% 
(PC 0.05; n = 3). The heat-stable activator of calcium- 
dependent nitric oxide synthesis was probably identical 
with calmodulin, since 3 .O +- 0.1 PM calmodulin/mg 
cytosolic protein was detected in endothelial cytosol 
(n = 12) by a specific radioimmunoassay. 
The endogenous calmodulin was removed by partial 
purification of nitric oxide synthase utilizing anion ex- 
change chromatography. Nitric oxide synthase activity 
in the effluent from a Mono-Q column was not detec- 
table unless procine brain calmodulin and 2 PM free 
Ca2+ were added. As shown in Fig. 1, partially purified 
nitric oxide synthase was half-maximally activated by 
100 nM calmodulin. Ca2+-calmodulin (0.3 PM)- 
reconstituted partially purified nitric oxide synthase 
was inhibited with similar potency by the peptide cal- 
modulin antagonist, melittin, and by calmidazolium 
(Fig. 2a). In contrast, the Ca2+-dependent activation of 
nitric oxide synthase in the cytosol was inhibited by the 
Ca2+-calmodulin-dependent protein phosphatase 
calcineurin and the peptides mastoparan and melittin 
with an ICSO of 60, 350 and 450 nM but not by 
calmidazolium (Fig. 2b). The inhibition of 
Ca2+-dependent crude nitric oxide synthase in the 
cytosol by the peptide calmodulin inhibitors (1 FM) was 
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Fig. 3. (a) Free Ca 2+ 2 ( p M) enhances the increase in guanylate 
cyclase (GC) activity elicited by endothelial cytosol (0.1 mg 
protein/ml) in the presence of L-arginine (0.3mM) and NADPH 
(0.1 mM) (open columns). Calmodulin (CaM) antagonists (melittin, 
calcineurin, both 1 PM) significantly inhibit Ca’+-cytosol-stimulated 
GC activity (P< 0.05; n = 20; cross-hatched columns). Porcine brain 
calmodulin (1 PM) significantly reverses this inhibition (hatched 
columns). @) Porcine brain calmodulin reverses melittin-induced 
inhibition (f a) of Ca*+-cytosol-stimulated guanylate cyclase (GC) 
activity (*); (0) control in the absence of me&tin. Results from at 
least 4 independent experiments performed in triplicate. Incubation 
conditions as in Fig. 2. 
concentration-dependently reversed by simultaneous 
addition of calmodulin (1 FM) (Fig. 3a and b). 
4. DISCUSSION 
The Ca’+-dependent formation of an activator of 
soluble guanylate cyclase from L-arginine by cytosol 
from native and cultured aortic endothelial cells has 
recently been reported [4,5,7]. This activator was pro- 
bably identical with nitric oxide, since nitric oxide was 
detected in cytosolic incubates by chemiluminescence 
[9]. According to these findings the Ca*+-dependency 
of agonist-induced EDRF/nitric oxide release from in- 
tact endothelial cells [6, lo] is caused by a direct Ca*+ 
sensitivity of the endothelial nitric oxide-forming 
enzyme. 
In the present investigation we provide evidence that 
calmodulin or a calmodulin-like protein mediates the 
stimulatory effect of Ca*+ on endothelial nitric oxide 
synthase. This is substantiated by the findings that: (i) 
reconstitution of calmodulin to partially purified nitric 
oxide synthase was required for the stimulating effect 
of Ca*+; (ii) the Ca*+-calmodulin-reconstituted nzyme 
was inhibited by the calmodulin antagonists melittin 
and c~mid~olium; (iii) the Ca2+-dependent formation 
of nitric oxide in endothelial cytosol was inhibited by 
the calmodulin antagonists, melittin, mastoparan and 
calcineurin, which bind with high affinity to cal- 
modulin (& around 1 nM) [ 1 1 - 131; (iv) calmodulin and 
heat-denatured endothelial cytosol, which contained 
high amounts of calmodulin as detected by radioim- 
munoassay, competitively reversed the inhibition of 
Ca’+-dependent nitric oxide synthesis by calmodulin in- 
hibitors. 
The lack of inhibition of nitric oxide synthesis in the 
cytosol by the pharmacological calmodulin inhibitors, 
calmidazolium and trifluoperazine, as observed in this 
study and by others [5,14] may be explained by the 
observation that pharmacological calmodulin in- 
hibitors are by orders of magnitude less potent in crude 
tissue extracts than expected from their Ki values ob- 
tained with purified calmodulin-dependent target en- 
zymes [15,16]. 
Previous studies have shown a stimulating effect of 
calmodulin inhibitors on EDFR release from intact 
cells 117,181. At first glance, this stimulation is difficult 
to reconcile with the ~a*~-calmodulin-dependence of 
nitric oxide synthesis. However, the endothelium- 
dependent relaxations elicited by melittin [17], and the 
potentiation of ATP-induced EDRF release from 
cultured endothelial cells by calmidazolium and fen- 
diline 1181 may be caused by the membr~e-pe~urbing 
properties of these compounds, resulting in an increas- 
ed Ca*+ influx into the endothelial cells [18,19]. Thus 
the effect of calmodulin inhibitors on intact endothelial 
cells may be the net result of a complex interference of 
these compounds with the membrane, the Ca2+ 
homeostasis, and the c~modulin-dependent nitric ox- 
ide synthesis. 
During preparation of this manuscript, a similar 
Ca*+-calmodulin-dependency of nitric oxide synthase 
isolated from rat cerebellum has been reported [20]. In 
contrast, activation of nitric oxide synthase from LPS- 
stimulated murine bone marrow macrophages was 
completely independent of the cytosolic Ca*+ level [21]. 
Therefore it appears that only those cells (e.g. en- 
dothelial and neuronal cells) which are supposed to res- 
pond quickly to humoral signals, possess a Ca2+- 
calmodulin-dependent nitric oxide synthase. This en- 
zyme allows the signal transduction of agoinst-induced 
Ca2+-transients into nitric oxide formation. 
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